Description

Weight loss is one of the few factors that have consistently been shown to be associated with shortened survival in people with lymphoma. This study aims to document how often dogs experience weight loss or decrease in muscle mass at the time that lymphoma is diagnosed, and whether this finding impacts how dogs respond to treatment.

Inclusion Criteria

Dogs with multicentric lymphoma that have undergone full staging.

Exclusion Criteria

Prior chemotherapy (including prednisone) or dogs with lymphoma within the gastrointestinal tract.

Client Benefits

None

Contact Information

Kelly Reed, Oncology Liaison
Phone: (508) 887-4682